Our results showed that MBZ significantly down-regulated cancer stemness markers, including CD24, CD44, and EpCAM, in both OVCAR3 and OAW42 cells, but the effects were more pronounced in OVCAR3 cells. This evidence concerns the gene CD44 and cancer.